English
img

Global elit de environmental

Et Safety New Material Solutions

Active pharmaceutical ingredient API et pharmaceutical medium

Nos focus in developing et synthesizing Tinib Apis et related intermedia. Currently sumus capaces supplendi API Alectinib, Palbociclib,
Pemigatinib et alia generis intermedia Alectinib, Palbociclib, Pemigatinib, infigratinib, rimegapant, Palsetinib, Sotorasib.


Detail

XII (II)
Nomen Structura Cas No. Annua output
Alectinib  XII (I) 1256580-46-7 V kg
 Object I 1256698-41-5 XX kg
 Object II 1256584-75-4 L kg
 Object III 939-80-0 MDCCC kg
 Object IV 1256584-73-2 MM kg
 V quod 53617-35-9 DLX kg
Nomen Structura Cas No. Annua output
V-aminoisophthalica acidum VI obiecti 13290-96-5 M T
 Object VII 618-88-2 DCCC T
 Object VIII 99-31-0 DL T

Nomen

Structura

Cas No.

Annua output

Lorolatinib

  Object IX

1454848-24-8

X kg
 Object X

1643141-20-1

XX kg
XI Object

1454846-35-5

X g

Nomen

Structura

Cas No.

Annua output

Pemigatinib

  Object XII

958230-19-8

I kg
 Object XV

651734-54-2

L kg
Object XIV

1513857-77-6

I g

Nomen

Structura

Cas No.

Annua output

Infigratinib

Bgj, CCCXCVIII

  Object XV

872509-56-3

X kg
 Object XVI

10272-07-8

L kg

Nomen

Structura

Cas No.

Annua output

Rimegepant

 Object XVII

1373116-06-3

10Kg
 Object XVIII

1190363-46-2

100g

Alias ​​intermedia

Nomen

Structura

Cas No.

Annua output
   XXII

364-78-3

II T
 Object XXIII

2897-43-0

CCC kg
Object XXIV

3753-18-2

XX T

Relinque nuntium tuum Company

Scribere nuntium hic mitte nobis

Relinque nuntium

Percute Enter ad quaerere vel ESC ad claudere